One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Visceral Adipose Tissue Volumetrics Inform Odds of Treatment Response and Risk of Subsequent Surgery in IBD Patients Starting Antitumor Necrosis Factor Therapy
Phillip Gu, MD, Avneesh Chhabra, MD, Punya Chittajallu, MD, Christopher Chang, MD, Denisse Mendez, MD, Andrew Gilman, MD, David I Fudman, MD, Yin Xi, PhD, Linda A Feagins, MD
doi : 10.1093/ibd/izab167
Volume 28, Issue 5, May 2022
Development of a Personalized Intestinal Fibrosis Model Using Human Intestinal Organoids Derived From Induced Pluripotent Stem Cells
Hannah Q Estrada, BS, Shachi Patel, MS, Shervin Rabizadeh, MD, David Casero, PhD, Stephan R Targan, MD, Robert J Barrett, PhD
doi : 10.1093/ibd/izab292
Endoscopic Prediction of Crohn’s Disease Postoperative Recurrence
Peter De Cruz, MD, PhD, Amy L Hamilton, PhD, Kathryn J Burrell, RN, Alexandra Gorelik, MSc, Danny Liew, MD, PhD, Michael A Kamm, MD, PhD
doi : 10.1093/ibd/izab134
Pharmacokinetic-Pharmacodynamic Model of Vedolizumab for Targeting Endoscopic Remission in Patients With Crohn Disease: Posthoc Analysis of the LOVE-CD Study
Jurij Hanzel, MD, Erwin Dreesen, PharmD, PhD, Séverine Vermeire, MD, PhD, Mark Löwenberg, MD, PhD, Frank Hoentjen, MD, PhD, Peter Bossuyt, MD, PhD, Esmé Clasquin, MSc, Filip J Baert, MD, PhD, Geert R D’Haens, MD, PhD, Ron Mathôt, PharmD, PhD
doi : 10.1093/ibd/izab143
Development and Validation of a Pediatric MRI-Based Perianal Crohn Disease (PEMPAC) Index—A Report from the ImageKids Study
Sapir Choshen, MD, Dan Turner, MD, PhD, Li-Tal Pratt, MD, Ronit Precel, MD, Mary-Louise Greer, MBBS, Denise A Castro, MD, Amit Assa, MD, MHA, MarÃa I MartÃnez-León, MD, Izabela Herman-Sucharska, MD, PhD, Eva Coppenrath, MD, Osnat Konen, MD, Jorge Davila, MD, Elhamy Bekhit, MBBS, Zehour Alsabban, MD, Gili Focht, MBA, Matan Gavish, PhD, Anne Griffiths, MD, Ruth Cytter-Kuint, MD
doi : 10.1093/ibd/izab147
Posttraumatic Stress in Patients With Inflammatory Bowel Disease: Prevalence and Relationships to Patient-Reported Outcomes
Tiffany H Taft, PsyD, MIS, Sarah Quinton, PsyD, Sharon Jedel, PsyD, Madison Simons, PsyD, Ece A Mutlu, MD, Stephen B Hanauer, MD
doi : 10.1093/ibd/izab152
Swapping Versus Dose Optimization in Patients Losing Response to Adalimumab With Adequate Drug Levels
Xavier Roblin, MD, PhD, Capucine Genin, MD, Stéphane Nancey, MD, PhD, Nicolas Williet, MD, PhD, Pauline Veyrard, MD, Gilles Boschetti, MD, PhD, Jean-Marc Phelip, MD, PhD, Anne-Emmanuelle Berger, MD, Martin Killian, MD, PhD, Louis Waeckel, PharmD, Bernard Flourie, MD, PhD, Stéphane Paul, PhD
doi : 10.1093/ibd/izab158
Anxiety and Depressive Symptoms Are Not Associated With Future Pediatric Crohn’s Disease Activity
Erica J Brenner, MD, MSCR, Millie D Long, MD, MPH, Courtney M Mann, MA, CCRP, Li Lin, MS, Wenli Chen, MS, MA, Camila Reyes, MS, Kirsten M Bahnson, BA, Bryce B Reeve, PhD, Michael D Kappelman, MD, MPH
doi : 10.1093/ibd/izab162
Efficacy of Vedolizumab in a Nationwide Cohort of Elderly Inflammatory Bowel Disease Patients
Nabeel Khan, MD, Tyler Pernes, BA, Alexandra Weiss, MD, Chinmay Trivedi, MBBS, Manthankumar Patel, MS, Elina Medvedeva, MS, Dawei Xie, PhD, Yu-Xiao Yang, MD
doi : 10.1093/ibd/izab163
Colorectal Cancer Prevention in Inflammatory Bowel Disease: A Systematic Analysis of the Overall Quality of Guideline Recommendations
Simcha Weissman, DO, Hannah K Systrom, MD, Muhammad Aziz, MD, Mohammed El-Dallal, MD, Wade Lee-Smith, MLS, Michael Sciarra, DO, Joseph D Feuerstein, MD
doi : 10.1093/ibd/izab164
Fecal Amino Acid Analysis in Newly Diagnosed Pediatric Inflammatory Bowel Disease: A Multicenter Case-Control Study
Jasmijn Z Jagt, MD, Eduard A Struys, PhD, Ibrahim Ayada, MD, Abdellatif Bakkali, BSc, Erwin E W Jansen, BSc, Jürgen Claesen, PhD, Johan E van Limbergen, MD, PhD, Marc A Benninga, MD, PhD, Nanne K H de Boer, MD, PhD, Tim G J de Meij, MD, PhD
doi : 10.1093/ibd/izab256
TIPE2 Promotes Tumor Initiation But Inhibits Tumor Progression in Murine Colitis-Associated Colon Cancer
Zienab Etwebi, PhD, Jason R Goldsmith, MD, PhD, Mayassa Bou-Dargham, PhD, Yuhua Tian, PhD, Ryan Hood, BA, Nina Spitofsky, BA, Mingyue Li, PhD, Honghong Sun, PhD, Yunwei Lou, PhD, Suxia Liu, MD, PhD, Christopher Lengner, PhD, Youhai H Chen, MD, PhD
doi : 10.1093/ibd/izab306
Meta-Analysis of IBD Gut Samples Gene Expression Identifies Specific Markers of Ileal and Colonic Diseases
Kevin Perez, PhD, Marjolaine Ngollo, PhD, Keren Rabinowitz, PhD, Nassim Hammoudi, MD, Philippe Seksik, MD, PhD, Ramnik J Xavier, MD, PhD, Mark J Daly, PhD, Iris Dotan, MD, PhD, Lionel Le Bourhis, PhD, Matthieu Allez, MD, PhD
doi : 10.1093/ibd/izab311
Intestinal Ultrasound in Pediatric Inflammatory Bowel Disease: Promising, but Work in Progress
Elsa A van Wassenaer, MD, Marc A Benninga, MD, PhD, Johan L van Limbergen, MD, PhD, Geert R D’Haens, MD, PhD, Anne M Griffiths, MD, PhD, Bart G P Koot, MD, PhD
doi : 10.1093/ibd/izab125
A Framework for Clinical Trials of Neurobiological Interventions That Target the Gut-Brain Axis in Inflammatory Bowel Disease
Chung Sang Tse, MD, Siddharth Singh, MBBS, William J Sandborn, MD
doi : 10.1093/ibd/izab153
Reducing Pain in Experimental Models of Intestinal Inflammation Affects the Immune Response
Laura Golusda, Anja A Kühl, PhD, Britta Siegmund, MD, Daniela Paclik, PhD
doi : 10.1093/ibd/izab290
Patient Portal Usage: An Objective Target for Transition Interventions Among Youth with IBD?
Jeannie S Huang, MD, MPH, Matthew Definis, BA, Rusvelda Cruz, MPH, Jacob Parker, BS
doi : 10.1093/ibd/izab231
Characterization of Mycophenolate Mofetil Gastrointestinal Toxicity and Risk Factors for Severe Disease and Poor Prognosis
Sumona Bhattacharya, MD, Gianna Stoleru, MD, Preet Patel, MD, Ameer Abutaleb, MD, MS, Kristen Stashek, MD, Raymond K Cross, MD, MS
doi : 10.1093/ibd/izab254
Corrigendum to: Intracolonic Neuropeptide Y Y1 Receptor Inhibition Attenuates Intestinal Inflammation in Murine Colitis and Cytokine Release in IBD Biopsies
Bindu Chandrasekharan, PhD, Darra Boyer, BS, Joshua A Owens, PhD, Alexandra A Wolfarth, PhD, Bejan J Saeedi, PhD, Tanvi Dhere, MD, Heba Iskandar, MD, Andrew S Neish, MD
doi : 10.1093/ibd/izab294
Corrigendum to: Meta-Analysis of IBD Gut Samples Gene Expression Identifies Specific Markers of Ileal and Colonic Diseases
Kevin Perez, PhD, Marjolaine Ngollo, PhD, Keren Rabinowitz, PhD, Nassim Hammoudi, MD, Philippe Seksik, MD, PhD, Ramnik J Xavier, MD, PhD, Mark J Daly, PhD, Iris Dotan, MD, PhD, Lionel Le Bourhis, PhD, Matthieu Allez, MD, PhD
doi : 10.1093/ibd/izac016
Corrigendum to: Pharmacokinetic-Pharmacodynamic Model of Vedolizumab for Targeting Endoscopic Remission in Patients with Crohn Disease: Posthoc Analysis of the LOVE-CD Study
Jurij Hanzel, MD, Erwin Dreesen, PharmD, PhD, Séverine Vermeire, MD, PhD, Mark Löwenberg, MD, PhD, Frank Hoentjen, MD, PhD, Peter Bossuyt, MD, PhD, Esmé Clasquin, MSc, Filip J Baert, MD, PhD, Geert R D’Haens, MD, PhD, Ron Mathôt, PharmD, PhD
doi : 10.1093/ibd/izab270
Corrigendum to: Multifaceted Secukinumab-induced Colitis
Alexandros G Sykaras, MD, Evangelia Margellou, MD, Natalia G Vallianou, PhD, Fotis Panagopoulos, MSc, Eleni Geladari, MSc, Dimitris Kounatidis, MSc, Ioannis Alevizakis, MD, Christina Magkou, PhD
doi : 10.1093/ibd/izab338
Letter to the Editor in Response to “Immunogenicity of Tumor Necrosis Factor Antagonists and Effect of Dose Escalation on Anti-Drug Antibodies and Serum Drug Concentrations in Inflammatory Bowel Disease�
Neasa Mc Gettigan, MB, BCh, BAO, MRCPI, MSc, Karen Boland, MB, BCh, BAO, MRCPI, Aoibhlinn O’Toole, MB, BCh, BAO, MRCPI
doi : 10.1093/ibd/izab282
Authors’ Reply to “Immunogenicity of Tumor Necrosis Factor Antagonists and Effect of Dose Escalation on Anti-Drug Antibodies and Serum Drug Concentrations in Inflammatory Bowel Disease�
Robert Battat, MD
doi : 10.1093/ibd/izab283
Crohn’s Disease Complicated by an Ileo-urachal Fistula
Qiu-Feng Zhao, MD, Song Wang, MD
doi : 10.1093/ibd/izab280
A Survey of Endoscopists’ Views on Dysplasia Surveillance and Chromoendoscopy in IBD from India
Gaurav B Nigam, MBBS, DNB, MMed, MRCP, Rajan N Patel, MBBS MRCP, Sundeep Lakhtakia, MD, MNAMS, DM, Devendra Desai, MBBS, MD, DNB, Govind Makharia, MBBS, MD, DM, Vineet Ahuja, MBBS, MD, DM, Jimmy K Limdi, MBBS, AGAF
doi : 10.1093/ibd/izab308
Mesalamine-Induced Perimyocarditis: Rare Adverse Event in a Patient With Acute Severe Ulcerative Colitis
Anuraag Jena, MD, DM, Anupam Kumar Singh, MD, DM, Bikkina Venkat Siddharda, MD, Prashant Panda, MD, DM, Vishal Sharma, MD, DM
doi : 10.1093/ibd/izab288
Sudden-Onset Polyposis in Pediatric Patients With Ulcerative Colitis
Soon Chul Kim, MD, PhD
doi : 10.1093/ibd/izab317
Wernicke Encephalopathy in Ulcerative Colitis
Roberto de Sire, MD, Antonio Rispo, MD, PhD, Debora Compare, MD, PhD, Fabio Tortora, MD, Gerardo Nardone, MD, Fabiana Castiglione, MD
doi : 10.1093/ibd/izab296
